A. Af, R. P. , and H. Sm, Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicants patients with bilateral above-knee femoropopoliteal bypasses, Surgery, vol.126, issue.4, pp.594-601, 1999.

A. Nationale-d, Accréditation et d'Evaluation en Santé (ANAES), Echographie- Doppler dans l'artériopathie oblitérante des membres inférieurs, 2002.

-. , R. Rr, N. Pr, H. A. , and K. Vs, Prescribing patterns of antiplatelet agents are highly variable after lower extremity endovascular procedures, Ann Vasc Surg, vol.27, issue.1, pp.62-67, 2013.

A. Dj, F. , B. E. , R. C. , S. M. Banuelos-c et al., High clopidogrel loading dose during coronary stenting : effects on drug response and interindividual variability, Eur Heart J, issue.21, pp.251903-1910, 2004.

A. Dj, F. , B. E. , R. C. , S. M. et al., Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment, Diabetes, issue.8, pp.542430-2435, 2005.

-. , B. E. , R. C. , C. M. , S. M. et al., Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment, J Am Coll Cardiol, issue.2, pp.48298-304, 2006.

-. , K. Mj, K. Jm, and H. Wr, Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials, JAMA, issue.18, pp.3011909-1919, 2009.

-. , H. F. , K. J. , S. A. , and D. Hc, Clopidogrel versus aspirin in patients with atherothrombosis : a CAPRIE-based calculation of costeffectiveness for Germany, Curr Med Res Opin, vol.24, issue.1, pp.267-274, 2008.

-. , R. Hj, U. P. , G. Ah, and . Investigators, Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting ; the clopidogrel aspirin stent international cooperative study, Circulation, issue.6, pp.102624-629, 2000.

-. Dl, F. K. , H. W. Berger-pb, B. Hr, C. P. Boden-we et al., Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events, N Engl J Med, issue.16, pp.3541706-1717, 2006.

-. Nimmo-af, G. Oj, M. J. , D. Ar, F. K. et al., Randomized controlled trial of dual antiplatelet therapy in patients undergoing surgery for critical limb ischemia, Ann Surg, vol.252, issue.1, pp.37-42, 2010.

B. Dhc, K. Ap, B. Van-bockel-jh, and . Pj, A prospective randomized trial comparing vein with PTFE in above knee femoropopliteal bypass grafting, J Vasc Surg, vol.32, issue.2, pp.278-283, 2000.

-. Committee, A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE), Lancet, issue.9038, pp.3481329-1339, 1996.

-. Bachoo-p and B. J. , The role of platelets in peripheral vascular disease, Eur J Vasc Endovasc Surg, vol.25, issue.1, pp.6-15, 2003.

C. K. , F. I. , G. M. Bachoo-p, and B. J. , Randomized clinical trial of the antiplatelet effects of aspirin-clopidogrel combination versus aspirin alone after lower limb angioplasty, B J Surg, issue.2, pp.92159-165, 2005.

-. , S. M. , J. Mr, L. Gy, T. M. et al., Antithrombotic therapy in peripheral arterial occlusive disease : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy Failure of certain antiplatelet drugs to affect myointimal thickening following arterial injury, Chest Lab Invest, vol.126, issue.34, pp.609-626, 1977.

-. Ca, A. Tj, A. Lk, C. Ad, and W. Jh, Random control trial of a short course of asprin and dipyridamole (Persantin) for femorodistal grafts, Br J Surg, vol.74, issue.4, pp.246-248, 1987.

-. Cw, H. Gb, F. E. Bouchard-a, M. D. , R. K. et al., Cigarette smoking and peripheral arterial occlusive disease, Surgery, vol.114, issue.4, pp.756-757, 1993.

-. , C. T. , R. G. , C. G. , E. S. et al., Bedside monitoring to adjust antiplatelet therapy for coronary stenting, N Engl J Med, issue.22, pp.3672100-2109, 2012.

-. De-poli-f, T. C. , F. F. , H. M. , and D. Mc, Le stent " actif " en 2005 : remplit-il ses promesses ? Annales de Cardiologie et d'Angéiologie, pp.54325-331, 2005.

-. Langer-rd, F. A. , F. Hs, K. Mr, T. Mccann et al., Mortality over a period of 10 years in patients with peripheral arterial disease, N Engl J Med, issue.6, pp.326381-386, 1992.

-. , F. C. , Q. J. , M. Pe, N. et al., Benefit of a 600-mg loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non- ST-segment elevation acute coronary syndrome undergoing coronary stenting, J Am Coll Cardiol, issue.7, pp.481339-1344, 2006.

C. T. , F. C. , Q. J. , P. R. , G. B. et al., Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study

C. T. , F. C. , Q. J. , G. B. , B. L. et al., Aspirin noncompliance is the major cause of « aspirin resistance " in patients undergoing coronary stenting, Am Heart J, issue.5, pp.157889-893, 2009.

-. , M. Jl, J. S. , C. Cp, and S. Ms, Interaction between cigarette smoking and clinical benefit of clopidogrel, J Am Coll Cardiol, issue.15, pp.531273-1278, 2009.

D. J. Bilden-kp, T. Us, H. Ms, A. Mj, S. Ta et al., The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients : an analysis from the aspirin-induced platelet effect (ASPECT) study. Diabetes, pp.563014-3019, 2007.

-. Salter-mcp, K. Rc, R. Sm, H. Tj, S. N. et al., The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts, Vasc Endovasc Surg, vol.19, issue.4, 1985.

-. , L. B. , M. Ne, J. Cw, B. Jn et al., Treatment of hyperlipidaemia retards progression of symptomatic femoral atherosclerosis. A randomized controlled trial, Lancet, issue.28351, pp.639-642, 1983.

-. Anticoagulants, . Aspirin, . Boa, . Study, and . Group, Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants of Aspirin Study), Lancet, issue.9201, pp.355346-351, 2000.

-. Jn, Chirurgie des vaisseaux 1 ? Aspects fondamentaux, Arnette, 1994.

-. Hh, B. Jj, S. O. , and P. D. , Protecting the heart with cardiac medication in patients with left ventricular dysfunction undergoing major noncardicac vascular surgery, Seminar in Cardiothoracic and Vascular Anesthesia, pp.25-31, 2006.

-. and C. Ja, Role of platelets and platelets inhibitors in aortocoronary artery vein-graft disease, Circulation, vol.73, issue.2, pp.227-232, 1986.

-. , D. Bc, A. , P. L. , H. R. et al., Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency, Vascular, vol.22, issue.2, pp.105-111, 2014.

G. J. , J. L. , T. C. , K. J. , S. M. et al., Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomized patients I : one year results of functional and physiological improvements, Eur J Vasc Endovasc Surg, issue.2, p.22, 2001.

G. M. , A. B. , C. J. , L. Gal-g, L. K. et al., Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin : the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study, J Am Coll Cardiol, issue.3, pp.51256-260, 2008.

G. M. , N. Hc, D. Z. Hawker-rj, and M. Cn, Platelet accumulation on mature Dacron grafts in man, Br J Surg, vol.69, pp.38-40, 1982.

G. M. Mc, A prospective randomized study to examine the effect of aspirin plus dipyridamole on the patency of prosthetic femoro-popoliteal grafts, Vasc Endovasc Surg, vol.18, issue.4, pp.217-221, 1984.

-. , R. Lr, and D. Ja, Effects of aspirin and dipyridamole on expanded polytetrafluoroethylene graft patency, Surgery, vol.92, issue.6, pp.1016-1026, 1982.

-. , A. Vm, M. T. , W. Jr, and M. N. , Prosthetic above-knee femoropopliteal bypass : a five year randomized trial, J Vasc Surg, issue.3, pp.31417-425, 2000.

G. T. Steiner-s, S. D. , K. R. , P. S. , and K. Cw, Smoking promotes clopidogrel-mediated platelet inhibition in patients receiving dual antiplatelet therapy, Thromb Res, vol.124, issue.5, pp.588-591, 2009.

-. , S. Hw, and H. Iw, Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients, Thromb Res, issue.5, pp.71397-403, 1993.

G. Pa, L. Bilden-kp, K. Dk, L. Dj, W. A. Kc et al., The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel : the PARADOX study, J Am Coll Cardiol, issue.6, pp.62505-512, 2013.

-. , S. Td, and L. T. , Rentabilité du clopidogrel dans la prevention secondaire cardiovasculaire : une analyse coût-efficacité sur la base de l'étude CAPRIE, Médecine et hygiène, pp.591749-1754, 2001.

H. Autorité and D. Santé, Prise en charge de l'artériopathie chronique oblitérante athéroscléreuse des membres inférieurs ? Indications médicamenteuses, de revascularisation et de rééducation, 2006.

-. Bolin-km, H. J. , W. Sr, M. A. , T. Kl et al., Development of aspirin resistance in persons with previous ischemic stroke, Stroke, issue.12, pp.252331-2336, 1994.

H. Wr, Medical treatment for peripheral arterial disease and claudication, N Engl J Med, issue.21, pp.3441608-1621, 2001.

-. , H. Zj, H. Nr, and B. Cw, ACC/AHA 2005 Practice Guidelines for the Management of Patients with Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric and Abdominal Aortic), Circulation, issue.11, pp.113463-654, 2006.

-. , T. D. , F. D. , B. P. , F. B. et al., Time dependence of platelet inhibition after a 600-mg loading dose of clopidogrel in a large, unselected cohort of candidates for percutaneous coronary intervention, Circulation, issue.20, pp.1112560-2564, 2005.

-. , C. Ck, and F. R. , Anastomosis and fluid dynamics, ESVB 2009 ? New technologies in vascular biomaterials, connecting biomaterials to arterial structures, 2009.

-. , B. J. , C. Nl, C. J. , C. Gr et al., Does oral anticoagulation improve patency of vein bypasses ? A prospective randomized study, 51st Annual Meeting, SVS, 1997.

-. Wc and L. Kk, A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoro-popliteal above-knee revascularization : a prospective randomized Department of Veterans Affairs Cooperative Study, J Vasc Surg, issue.2, pp.32268-277, 2000.

J. Wc and W. Wo, Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures : a prospective randomized study, J Vasc Surg, issue.3, pp.35413-421, 2002.

-. , G. S. , P. S. Main-c, O. V. , S. M. et al., Clinical effectiveness and costeffectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events : a systematic review and economic evaluation, Health Technol Assess, issue.38, pp.81-196, 2004.

-. , R. C. , A. Mc, A. Jp, H. M. et al., Increased plasminogen activor inhibitor activity in non insulin dependent diabetic patients ? relationship with plasma insulin, Thromb Haemost, issue.3, p.61, 1989.

K. J. Brennan-a, P. A. , F. G. , L. A. , G. D. et al., Modelling the long term cost-effectiveness of clopidogrel for the secondary prevention of occlusive vascular events in the UK, Curr Med Res Opin, vol.21, issue.1, pp.101-112, 2005.

-. , K. W. , L. Hw, P. Dj, A. Jh et al., Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate : a randomized, open-label, crossover study in healthy Korean male subjects, Clin Ther, issue.4, pp.31793-803, 2009.

-. Ml, . White, . Jr, D. Bowers-wp, and . Ed, Cost incentives for peripheral angioplasty, AJR Am J Roentgenol, issue.6, pp.1451241-1244, 1985.

K. P. , S. A. Burger-dh, B. Van-bockel-jh, and . Pj, Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting : five year results of a randomized controlled trial, J Vasc Surg, vol.37, issue.1, pp.149-155, 2003.

-. , M. Wj, H. Hn, L. Cr, L. Ch et al., Early onset of subclinical atherosclerosis in young persons with type 1 diabetes, J Pediatr, vol.145, issue.4, pp.452-457, 2004.

-. , H. F. , P. M. , S. T. , W. E. et al., A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis, Arch Surg, issue.9, pp.1271112-1115, 1992.

-. , E. B. Watson-l, and L. Gc, Exercise for intermittent claudication

-. , W. La, W. Pb, N. Cj, H. K. et al., Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction, Cochrane Database Syst Rev Circulation, vol.7, issue.1071, pp.32-37, 2003.

-. , S. J. , T. Sw, M. H. , and L. , Variability of residual platelet function despite clopidogrel treatment in patients with peripheral arterial occlusive disease, Atherosclerosis, vol.209, issue.2, pp.504-509, 2010.

-. , H. Bm, H. J. Van-hout, and . Ba, Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high risk) atherosclerotic patients in Sweder : a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations, Appl Health Econ Health Policy, vol.8, issue.4, pp.251-265, 2010.

-. , C. C. , and B. Jf, Comment expliquer l'augmentation des thromboses chez le sujet âgé ? Presse médicale, pp.34887-895, 2005.

-. , A. C. , K. G. , F. Pj, and G. R. , Antiplatelet drugs in femoropopliteal vein bypasses : a multicenter trial, J Vasc Surg, vol.13, issue.1, pp.150-161, 1991.

-. , Y. S. Peters-rj, B. Me, L. Bs, N. Mk et al., Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by longterm therapy in patients undergoing percutaneous coronary intervention : the PCI- CURE study, Lancet, issue.9281, pp.358527-533, 2001.

-. , H. Wr, and C. Ma, Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease, Circulation, vol.108, pp.1481-1486, 2003.

M. M. , D. Tommaso-l, P. Gb, L. S. , S. V. et al., Combination therapy with warfarine plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients, J Vasc Surg, vol.56, issue.1, pp.96-105, 2012.

M. S. Ballo-p, B. R. , G. F. , A. T. , A. E. et al., Effects of simvastatine on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease, Am J Med, issue.5, pp.114359-364, 2003.

-. , E. Jc, L. Nieto-k, L. D. Mg, and W. Pw, Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study, Am Heart J, issue.6, pp.143961-965, 2002.

-. , G. C. , T. , B. Mn, R. M. Benedetti-c et al., Syndromes hémorragiques sous antidépresseurs inhibiteurs sélectifs de la recapture de la sérotonine (ISRS) ? A propos de sept cas et revue de la literature, pp.152-160, 2000.

-. , H. Wr, D. J. , N. Mr, and F. Fg, TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II), J Vasc Surg, vol.45, issue.1, pp.5-67, 2007.

-. , L. C. , P. S. Lehmann-s, T. M. , S. Jc et al., A randomized comparison of platelet reactivity in patients after treatment with various commercial clopidogrel preparations : the CLO-CLO trial, Arch Cardiovasc Dis, issue.11, pp.105587-592, 2012.

-. , T. Mj, B. Jj, . Van-hout, . Ba et al., Dutch Bypass Oral anticoagulants or Aspirin (BOA) Study Group. Cost-effectiveness of oral anticoagulants versus aspirin in patients after infrainguinal bypass grafting surgery

-. Sh, K. W. , P. Cs, K. Wy, H. Sh et al., A comparison of clopidogrel responsiveness in patients with versus without chronic renal failure, Am J Cardiol, vol.104, issue.9, pp.1292-1295, 2009.

-. , K. J. , P. K. , O. Ag, C. Tj et al., Effect of simvastatine on ischemic signs and symptoms in the Scandinavian simvastatine survival study, Am J Cardiol, issue.3, pp.81333-335, 1998.

-. , K. T. , M. , W. C. , K. et al., Dacron vs polytetrafluoroethylene grafts for femoropopliteal bypass. A prospective randomised multicentre trial Relationship between smoking and cardiovascular risk factors in the development of peripheral arterial disease and coronary artery disease : Edinburgh Artery Study, Eur J Vasc Endovasc Surg Eur Heart Journal JAMA, vol.22, issue.20511, pp.226-231344, 1999.

-. De, Impact du choix d'un antiagrégante plaquettaire dans l'artériopathie oblitérante des membres inférieurs sur les pertes de chances et sur les coûts médicaux, Journal des maladies vasculaires, vol.32, issue.1, pp.8-14, 2007.

-. , F. J. , T. P. , A. R. , H. Sj et al., A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed Dacron grafts for femoropopliteal bypass, Cardiovasc Surg, vol.7, issue.2, pp.214-218, 1999.

R. D. , M. Mj, R. Dm, J. Dh, E. J. et al., The effects of aspirin, dipyridamole and warfarine in femorodistal reconstruction: long-term results, Am Surg, issue.9, pp.53477-481, 1987.

-. , W. Jp, and O. Dk, Clopidogrel versus aspirin for seconday prophylaxis of vascular events : a cost-effectiveness analysis, Am J Med, issue.12, pp.116797-806, 2004.

S. Db, Interactions statines ? clopidogrel, Thèse de doctorat en médecine, 2005.

-. , A. Ak, R. A. , S. U. , K. M. et al., Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification : a singlecenter experience, J Endovasc Ther, issue.4, pp.15408-416, 2008.

-. Sr, B. Pb, M. Jt, F. Et, D. A. et al., Clopidogrel for the Reduction of Events During Observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial, JAMA, issue.19, pp.2882411-2420, 2002.

-. Sr, . Berger-pb, T. Brennan-dm, . Ej, D. Credo-investigators et al., Optimal timing for the initiation of pre-treatment with 300 mg clopidogrel before percutaneous coronary intervention Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery, J Am Coll Cardiol J Vasc Surg, vol.47, issue.53, pp.939-943, 2006.

-. , B. K. , S. J. , Z. T. , R. Mf et al., Twelve-month results of a randomized trial comparing mono with dual antiplatelet therapy in endovascularly treated patients with peripheral artery disease

-. , A. A. , L. J. , H. S. , and E. Bc, Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery

-. , B. R. , B. K. , S. J. , Z. T. et al., Management of peripheral arterial interventions with mono or dual antiplatelet therapy ? the MIRROR study : a randomised and double-blinded clinical trial, Eur Radiol, issue.9, pp.221998-2006, 2012.

-. Seguin-a and M. E. , Mesures de la pression transcutanée d'oxygène (TcPO 2 ), Angéiologie, pp.19-1100, 2008.

-. , T. Rl, and I. L. Van-allan-r, Should percutaneous transluminal angioplasty be recommended for treatment of infrageniculate popliteal artery or tibioperoneal trunk stenosis ?, J Vasc Surg, vol.22, issue.4, pp.464-465, 1995.

-. , G. Sk, A. R. , and W. , Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infra inguinal arterial reconstructions, J Vasc Surg, vol.3, issue.1, pp.104-114, 1986.

E. T. Al, P. Ts, N. R. , and P. Gl, Platelet dysfunction in type 2 diabetes, Diabetes Care, issue.8, pp.241476-1485, 2001.

-. , G. Bl, and S. P. , Atlas de chirurgie vasculaire, 2007.